Latest Posts
Kusserow on Compliance: First steps in conducting witness interviews
September 16, 2019 By Richard Kusserow
Witnesses are key to most investigations and are most often neutral third-parties from whom information is desired. Obtaining useful information and cooperation from witnesses is a critical part of any successful investigation and nothing can derail … [Read More...]
FDA moving to expand access to experimental drugs
September 13, 2019 By Wolters Kluwer Contributor
The FDA is taking steps to expand patients’ access to drugs that have not yet been approved for marketing, encouraging manufacturers to exclude fewer people from clinical trials and to publicize their policies about accessing drugs outside of … [Read More...]
Kusserow on Compliance: OIG Work Plan update on Hospital Sector
September 9, 2019 By Richard Kusserow
The HHS Office of Inspector General (OIG) Work Plan sets forth various audits and evaluations that are underway or planned during the fiscal year and beyond. Since June 2017, the OIG modifies the plan monthly to add new items and remove completed … [Read More...]
Recently on Law & Health
- Kusserow on Compliance: First steps in conducting witness interviews
- FDA moving to expand access to experimental drugs
- Kusserow on Compliance: OIG Work Plan update on Hospital Sector
- CVS-Aetna merger approved, subject to divestiture of PDP business
- Kusserow on Compliance: GAO reports CMS gaps in nursing home oversight
- Kusserow on Compliance: Preparing for compliance investigations
- National review of Medicaid opioid prescribing not yet feasible
- Kusserow on Compliance: OIG’s planned work for home health agencies
- Medicaid third-party liability changes a challenge for states
- Kusserow on Compliance: New OCR Guidelines
Cheetah
Law & Health on LinkedIn
